Target Price | €22.44 |
Price | €22.66 |
Deviation |
0.97%
register free of charge
|
Number of Estimates | 11 |
11 Analysts have issued a price target CompuGroup Medical 2026 .
The average CompuGroup Medical target price is €22.44.
This is
0.97%
register free of charge
€30.45
34.38%
register free of charge
€10.10
55.43%
register free of charge
|
|
A rating was issued by 18 analysts: 3 Analysts recommend CompuGroup Medical to buy, 8 to hold and 7 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the CompuGroup Medical stock has an average upside potential 2026 of
0.97%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion € | 1.15 | 1.20 |
2.83% | 4.16% | |
EBITDA Margin | 18.75% | 20.48% |
2.13% | 9.21% | |
Net Margin | 3.00% | 6.98% |
22.45% | 132.80% |
13 Analysts have issued a sales forecast CompuGroup Medical 2025 . The average CompuGroup Medical sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an CompuGroup Medical EBITDA forecast 2025. The average CompuGroup Medical EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 CompuGroup Medical Analysts have issued a net profit forecast 2025. The average CompuGroup Medical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | 0.66 | 1.62 |
25.00% | 145.45% | |
P/E | 13.98 | |
EV/Sales | 1.56 |
13 Analysts have issued a CompuGroup Medical forecast for earnings per share. The average CompuGroup Medical EPS is
This results in the following potential growth metrics and future valuations:
CompuGroup Medical...
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Locked
➜
Locked
|
Locked | Mar 31 2025 |
LANDESBANK BADEN-WUERTTEMBERG |
Locked
➜
Locked
|
Locked | Mar 30 2025 |
BAADER HELVEA EQUITY RESEARCH |
Locked
➜
Locked
|
Locked | Mar 17 2025 |
LANDESBANK BADEN-WUERTTEMBERG |
Locked
➜
Locked
|
Locked | Mar 10 2025 |
MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | Mar 09 2025 |
JEFFERIES |
Locked
➜
Locked
|
Locked | Mar 05 2025 |
BERENBERG |
Locked
➜
Locked
|
Locked | Dec 09 2024 |
Analyst Rating | Date |
---|---|
Locked
BERENBERG:
Locked
➜
Locked
|
Mar 31 2025 |
Locked
LANDESBANK BADEN-WUERTTEMBERG:
Locked
➜
Locked
|
Mar 30 2025 |
Locked
BAADER HELVEA EQUITY RESEARCH:
Locked
➜
Locked
|
Mar 17 2025 |
Locked
LANDESBANK BADEN-WUERTTEMBERG:
Locked
➜
Locked
|
Mar 10 2025 |
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
Mar 09 2025 |
Locked
JEFFERIES:
Locked
➜
Locked
|
Mar 05 2025 |
Locked
BERENBERG:
Locked
➜
Locked
|
Dec 09 2024 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.